Your Notifications
All done, no notifications

What is Cholangiocarcinoma (Bile Duct Cancer)?

Cholangiocarcinoma is a rare cancer that develops in the bile ducts. Bile ducts are narrow tubes that transport bile (a fluid used to break down fats) from the liver and gallbladder to the small intestine.

It is an aggressive cancer, meaning it spreads quickly. Cholangiocarcinoma is usually diagnosed after it has progressed outside of the bile ducts. Cholangiocarcinoma, often known as bile duct cancer, most commonly affects persons over the age of 50, but it can occur at any age.

What is the Importance of Timely Treatment?

  • Early therapy is crucial for improving outcomes and raising survival rates in cholangiocarcinoma.
  • It prevents cancer from spreading to other organs, increasing therapy effectiveness.
  • Surgery may be an option if identified early, giving the best chance of long-term survival.
  • Delays in treatment can cause cancer to spread, resulting in problems such as jaundice, liver damage, and infection.
  • Targeted therapies, such as chemotherapy, can help with disease control and symptom management.
  • Timely intervention improves prognosis, reduces complications, and enhances the quality of life for patients.

What are the Common Symptoms of Cholangiocarcinoma (Bile Duct Cancer)?

Signs and symptoms of cholangiocarcinoma include:

  • Yellowing of your skin and the whites of your eyes (jaundice)
  • Intensely itching skin
  • White-coloured stools
  • Fatigue
  • Abdominal pain on the right side, just below the ribs
  • Losing weight without trying
  • Fever
  • Night sweats
  • Dark urine

Types of Bile Duct Cancer

Cholangiocarcinoma is categorised into three types:

  • Intrahepatic Cholangiocarcinoma: It's bile duct carcinoma in your liver.
  • Perihilar (Hilar) Cholangiocarcinoma: It is bile duct carcinoma in the hilum. The hilum is the area right outside your liver where the smaller bile ducts from within your liver join to form the common hepatic duct. It is the most frequent type of cholangiocarcinoma. Perihilar cholangiocarcinoma is also known as Klatskin tumour.
  • Distal cholangiocarcinoma: It is Bile duct cancer that begins outside the liver, in the ducts closest to the small intestine.

Causes, Risk Factors and Complications of cholangiocarcinoma (Bile Duct Cancer)

Causes

Cholangiocarcinoma develops when cells in the bile ducts change their DNA. A cell's DNA includes instructions that teach it what to do. The modifications cause the cells to proliferate out of control, resulting in a mass of cells (tumor) that can infiltrate and kill healthy bodily tissue.

Risk Factors

The following factors may raise your risk of developing cholangiocarcinoma:

  • Primary sclerosing cholangitis: This condition hardens and scars the bile ducts.
  • Chronic liver illness: A history of chronic liver disease raises the likelihood of developing cholangiocarcinoma by scarring the liver.
  • Bile duct issues are evident at birth: People born with a choledochal cyst, which produces dilated and uneven bile ducts, are at a higher risk for cholangiocarcinoma.
  • A liver parasite. In Southeast Asia, cholangiocarcinoma is linked to liver fluke infection, which can result from eating raw or undercooked seafood.
  • Older age: Cholangiocarcinoma most commonly affects adults over the age of 50.
  • Smoking: Smoking is linked to an increased risk of cholangiocarcinoma.
  • Diabetes: People with type 1 or 2 diabetes may be at a higher risk for cholangiocarcinoma.

Complications

If cholangiocarcinoma is not treated or discovered immediately, it can cause significant complications:

  • Bile duct obstruction: This can cause jaundice, infection, or liver failure.
  • An infection of the bile ducts (Cholangitis)
  • Cancer-related liver failure.
  • Metastasis: Treatment becomes more complicated when cancer spreads to surrounding organs or distant bodily parts.
  • Blood clots: Cancer increases the risk of deep vein thrombosis and pulmonary embolism.

Connect with our advisor for a PRIORITY response

Latest Research and Technologies in the Treatment of Cholangiocarcinoma (Bile Duct Cancer) in Malaysia

  • Treatment advances for cholangiocarcinoma in Malaysia include immunotherapy with immune checkpoint inhibitors, especially for tumours with microsatellite instability, and targeted therapies with BRAF and MEK inhibitors for specific genetic mutations, providing more individualised and efficient treatment options.

Cholangiocarcinoma (Bile Duct Cancer) Prevention Tips

While it is not always possible to prevent cholangiocarcinoma, specific lifestyle changes and preventive measures can reduce the risk:

  • Avoid liver fluke infections by eating well-cooked fish and avoiding contaminated water in endemic areas.
  • Protecting oneself against infections, including hepatitis B, C, and HIV.
  • Hepatitis B vaccination can lower the chance of developing hepatitis-related liver cancer.
  • Maintain a healthy weight to lower your risk of obesity-related liver disorders, which are associated with cholangiocarcinoma.
  • Quit smoking to minimise your risk of developing liver cancer.
  • Limit your alcohol usage to lower your risk of developing cirrhosis and other liver problems.

Treatment options for Cholangiocarcinoma (Bile Duct Cancer)

Surgery: This involves removing all or part of your bile duct or damaged organs. Surgery can also treat a blocked duct that is generating symptoms. Your doctor may insert a stent (a short, hollow tube) to drain it or redirect the passage of bile around the obstruction.

Liver transplant: A liver transplant replaces your liver with a donor liver. A transplant is one possible treatment option for early-stage perihilar cholangiocarcinoma.
Radiation therapy: The use of radiation to kill cancer cells or shrink tumours. You may require external beam radiation therapy (EBRT), which directs radiation toward the cancer using a machine located outside your body.

Chemotherapy(chemo): Chemotherapy is a medication-based treatment that kills cancer cells or shrinks tumours. Systemic chemotherapy delivers the medication throughout your entire body. Transarterial chemoembolisation (TACE) involves inserting microscopic chemo beads into blood vessels near your tumour to reduce it. Hepatic artery chemo-infusion (HAI) involves injecting chemotherapy into the artery that pumps blood to your liver.


Cost Start From USD 1500 - USD 3500Explore Options

Targeted therapy: Targeted medicines inhibit the abnormal proteins that promote cancer growth.


Cost Start From USD 2000 - USD 10000Explore Options

Immunotherapy: Enhances your immune system's ability to fight cancer. Some bile duct cancer cells possess a protein that stops immune cells from attacking. Immunotherapy inhibits this protein, allowing immune cells to target the malignancy.


Cost Start From USD 15000 - USD 50000Explore Options

  • Liver function tests: These tests look for excessive substances in your blood, such as increased liver enzymes, which may suggest your liver isn't functioning correctly. High levels may indicate a bile duct blockage.
  • Tumour marker testing: These tests examine your blood or urine for tumour markers, which are compounds that may indicate malignancy. High levels of CA 19-9 or CEA may indicate bile duct cancer.
  • Imaging tests: An abdominal ultrasound is usually the first imaging test required if your doctor suspects bile duct cancer. You may also need a CT scan or an MRI, including a specific magnetic resonance cholangiopancreatography (MRCP).
  • Endoscopic tests: These evaluate your bile ducts with an endoscope, a thin, flexible tube with a camera attached. EUS (endoscopic ultrasound) and ERCP (endoscopic retrograde cholangiopancreatography) are two types of tests.
  • Percutaneous transhepatic cholangiography (PTC): It is a method for viewing and draining bile duct obstructions caused by cholangiocarcinoma.

Rehabilitation for Cholangiocarcinoma (Bile Duct Cancer) focuses on enhancing the quality of life and assisting with recovery after treatment. Here are some main rehabilitation options:

  • Physical therapy: This can help patients regain strength, mobility, and function after surgery, chemotherapy, or radiation. It helps to manage fatigue and boosts general physical well-being.
  • Psychosocial Support: Counselling and support groups assist patients in dealing with emotional and psychological difficulties associated with their diagnosis and treatment, such as anxiety, depression, or stress.
  • Occupational therapy: This aims to assist patients in regaining independence in daily tasks, especially if surgery or treatment results in physical limitations.

Depending on the circumstances, your doctor may prescribe medication to assist you in managing your symptoms and support your treatment plan.

Treatment regimens are adapted to the patient's specific cancer stage and location.

Instantly Connect with our Specialists

Doctor 1
Doctor 2
Doctor 3
Doctor 4
Doctor 5
Doctor 6
Doctor 7
Doctor 8

Hospitals for Cholangiocarcinoma (Bile Duct Cancer) in Malaysia

Sunway Medical Centre: Top Doctors, and Reviews
Sunway Medical Centre

Kuala Lumpur, Malaysia

Sunway Medical Centre has initiated a comprehensive expansion plan close to its current hospital facility to enhance its ability to provide services to the global market. The new Cancer Radiosurgery Center and Nuclear Medicine Center, which will also house additional Centers of Excellence like the Digestive Health Center and Dialysis Center, marked the completion of Tower C's first phase in October 2016.

Prince Court Medical Centre: Top Doctors, and Reviews
Prince Court Medical Centre

Kuala Lumpur, Malaysia

Prince Court is a private medical facility in the center of Kuala Lumpur that has 277 individual beds. Our dedication is to provide you with the best treatment possible from the time you arrive until you depart, healthier and happier. We are well-known for our top-notch facilities, cutting-edge technology, and friendly customer service.

Subang Jaya Medical Centre: Top Doctors, and Reviews
Subang Jaya Medical Centre

Kuala Lumpur, Malaysia

Subang Jaya Medical Center is renowned for pioneering radiation oncology treatments and infrastructure in Malaysia. The hospital also has a state-of-the-art Cancer Radiosurgery Centre (CRC), which is fully furnished with the latest medical technology for cancer detection, monitoring, and treatment.

Our Services to better your experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Why Choose Malaysia for Cholangiocarcinoma (Bile Duct Cancer) Treatment?

Here are some of the reasons for choosing Malaysia:

  • Oncology expertise: Malaysia has highly trained oncologists and specialised cancer centres that have treated cholangiocarcinoma before.
  • Advanced Treatment Options: Surgery, chemotherapy, radiotherapy, and targeted therapies, along with cutting-edge technology, are among the advanced treatment options available.
  • Cost-Effective Care: Treatment in Malaysia is cheaper than in many Western countries while maintaining high quality.
  • International Patient Services: Malaysian hospitals offer seamless treatment to international patients, including multilingual support and personalised services.
  • Accredited Healthcare Facilities: Malaysia's leading hospitals are JCI-accredited, providing high medical treatment standards.

Frequently Asked Questions

In Malaysia, people with cholangiocarcinoma who have early detection and curative treatment may have a favourable survival rate. Many individuals have better survival results with appropriate therapy, including surgical resection, highlighting the significance of prompt intervention for a better prognosis.

Standard chemotherapy side effects include nausea, vomiting, exhaustion, hair loss, and weakened immunity. These effects vary according to the medications used but are manageable with supportive care.

In Malaysia, clinical trials are essential for treating cholangiocarcinoma because they give patients access to novel treatments and ground-breaking drugs that are not yet generally accessible.

Researchers can examine possible drug combinations, targeted therapies, and immunotherapies that may enhance results thanks to these trials.

Additionally, they advance medical knowledge by enabling professionals to create future cholangiocarcinoma therapy alternatives better tailored to each patient's needs.

For those looking for high-quality care, treating cholangiocarcinoma (bile duct cancer) in Malaysia is more cost-effective than in Western nations. The therapy selected, the facility, and the patient's particular needs can all affect the cost of treatment.

Early-stage cholangiocarcinoma can benefit from surgical excision, and modern technologies and qualified surgeons increase the likelihood of success..

Cholangiocarcinoma is frequently discovered in its later stages due to mild signs in the early stages. Regular monitoring of those at higher risk (such as people with chronic liver problems) may aid in early diagnosis.

The length of treatment varies according to the type and stage of treatment. In contrast to chemotherapy or radiation, which can require months of rehabilitation with continuous follow-up care, surgery may only need a few weeks.

Yes, cholangiocarcinoma can spread to neighbouring organs such as the liver, pancreas, lymph nodes and other body regions. Early identification and treatment can reduce metastases and increase survival chances.

The chance of recurrence is determined by several factors, including the stage of the cancer at diagnosis, the type of treatment employed, and the patient's reaction to treatment. Regular follow-up treatment and surveillance are critical for spotting recurrences early.